Adage Capital Partners Gp, L.L.C. Centessa Pharmaceuticals PLC Transaction History
Adage Capital Partners Gp, L.L.C.
- $51.6 Billion
- Q1 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 6,954,000 shares of CNTA stock, worth $119 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
6,954,000
Previous 5,119,027
35.85%
Holding current value
$119 Million
Previous $85.7 Million
16.63%
% of portfolio
0.19%
Previous 0.16%
Shares
8 transactions
Others Institutions Holding CNTA
# of Institutions
135Shares Held
123MCall Options Held
163KPut Options Held
816K-
Medicxi Ventures Management (Jersey) LTD20MShares$342 Million74.33% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$170 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$166 Million4.7% of portfolio
-
Janus Henderson Group PLC London, X05.92MShares$101 Million0.05% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.34MShares$91.4 Million0.01% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.61B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...